Article By:
Noah Kiedrowski
Tuesday, February 6, 2018 3:12 PM EDT
The Biotechnology cohort has finally notched a 52-week high and has made up much of the lost ground during the pummeling from both sides of the political isle during the 2016 presidential race.
Biotech is Hot Sparked By Biotech M&A Deals for Juno and Bioverativ
I can't believe how high $JUNO has gone up since I've sold it. Big mistake.
Juno Therapeutics Shares Sky Rocket Following Buyout For $9 Billion
I can't believe I used to own this stock. Sold too soon! $JUNO
Biotech Buzz Is Broken
$KITE opened pretty good, $JUNO needs a bounce